Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > Corneal opacity is a major contributor to vision loss in the US, study finds
  • Cornea and External Disease

Corneal opacity is a major contributor to vision loss in the US, study finds

Kelsey Moroz

Corneal opacity, primarily caused by corneal dystrophies, significantly affects vision and leads to substantial vision loss in a notable portion of the population, according to a study highlighting significant disparities in vision outcomes based on gender and race.

Using data from the IRIS Registry, researchers conducted a retrospective cohort study from 5,220,382 patients diagnosed with corneal opacity from January 1, 2013, to November 30, 2020.

Key Findings

  • Prevalence: The corneal opacity case frequency was 6,535 per 100,000 patients, representing 6.5% of the study population.
  • Demographics: The average age of patients was 63.4 years, with 57.6% female. Most patients were White (69.1%), followed by Black or African American (6.8%), Asian (2.5%), American Indian or Alaska Native (0.3%), and Native Hawaiian or other Pacific Islander (0.2%). Hispanic or Latino patients made up 7.3%.
  • Etiologies: Corneal dystrophies were the most common cause (64.66%), followed by corneal edema (18.25%), ulcers (7.78%), keratoconjunctivitis (7.18%), degeneration (5.62%), neovascularization (6.27%), and trauma (5.28%).
  • Vision Outcomes: Corneal opacity caused significant vision loss that didn’t fully improve after treatment, with worse outcomes for females and non-White patients, especially those with severe corneal conditions.

The study underscores that corneal opacity, primarily caused by corneal dystrophies, affects a significant portion of patients and leads to substantial vision loss.

Reference
Singh RB, Dohlman TH, Ivanov A, et al; IRIS Registry Data Analytic Center Consortium. Corneal Opacity in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Study. Ophthalmology. 2024;S0161-6420(24)00416-0. doi: 10.1016/j.ophtha.2024.07.005. Epub ahead of print. PMID: 38986874.

Share

Related Content

  • Cornea and External Disease

Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

  • Conference Roundup

New screening device for keratoconus may help identify patients earlier

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon